These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10691820)

  • 21. [Follow up of urinary bladder cancer--a task for the urology nurse?].
    Fagerberg M; Nostell PO
    Lakartidningen; 2005 Jul 25-Aug 7; 102(30-31):2149-50. PubMed ID: 16111105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
    Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
    Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
    Steinbach F; Schuster F
    Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
    BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of nonlinear optimization for scheduling of follow-up cystoscopies to detect recurrent bladder cancer. The Bladder Cancer follow-up Group.
    Kent DL; Nease RA; Sox HC; Shortliffe LD; Shachter R
    Med Decis Making; 1991; 11(4):240-8. PubMed ID: 1662739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of urinary biomarkers for bladder cancer surveillance: patient perspectives.
    Yossepowitch O; Herr HW; Donat SM
    J Urol; 2007 Apr; 177(4):1277-82; discussion 1282. PubMed ID: 17382711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapy.
    Hall RR; Parmar MK; Richards AB; Smith PH
    BMJ; 1994 Jan; 308(6923):257-60. PubMed ID: 8179678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Utility of Rigid Blue Light Cystoscopy: Results from a Post Procedure User Survey in a Prospective Multicenter Registry.
    Stout TE; Regmi SK; Daneshmand S; Porten SP; Pohar KS; Konety BR
    Urol Pract; 2022 Jan; 9(1):94-100. PubMed ID: 37145566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.
    Lodde M; Mian C; Comploj E; Palermo S; Longhi E; Marberger M; Pycha A
    Urology; 2006 May; 67(5):950-4. PubMed ID: 16698355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey.
    Nielsen ME; Smith AB; Pruthi RS; Guzzo TJ; Amiel G; Shore N; Lotan Y
    BJU Int; 2012 Oct; 110(7):967-72. PubMed ID: 22487336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).
    Parmar MK; Freedman LS; Hargreave TB; Tolley DA
    J Urol; 1989 Aug; 142(2 Pt 1):284-8. PubMed ID: 2501516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in non-muscle invasive bladder cancer: lessons from a regional review.
    Siddins MT; Wong VV; Fitzgerald JT; Bamberg LJ
    ANZ J Surg; 2011 Dec; 81(12):889-94. PubMed ID: 22507415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upper tract surveillance in primary bladder cancer follow-up.
    Enver MK; Miller PD; Chinegwundoh FI
    BJU Int; 2004 Oct; 94(6):790-2. PubMed ID: 15476509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urologists' attitudes to the management of bladder cancer.
    Lynch TH; Waymont B; Dunn JA; Wallace DM
    Br J Urol; 1992 Nov; 70(5):522-5. PubMed ID: 1467859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer].
    Daniltchenko D; Riedl C; Koenig F; Daha LK; Sachs M; Schnorr D
    Aktuelle Urol; 2004 Nov; 35(6):497-501. PubMed ID: 15526230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.
    Schmitz-Dräger C; Bonberg N; Pesch B; Todenhöfer T; Sahin S; Behrens T; Brüning T; Schmitz-Dräger BJ
    Urol Oncol; 2016 Oct; 34(10):452-9. PubMed ID: 27381893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in pTa-pT1 superficial bladder tumours treated with intravesical instillations. The Dutch South-Eastern Urological Collaborative Group.
    Mulders PF; Meyden AP; Doesburg WH; Oosterhof GO; Debruyne FM
    Br J Urol; 1994 Apr; 73(4):403-8. PubMed ID: 8199828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urologist Use of Cystoscopy for Patients Presenting With Hematuria in the United States.
    David SA; Patil D; Alemozaffar M; Issa MM; Master VA; Filson CP
    Urology; 2017 Feb; 100():20-26. PubMed ID: 27645524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follow-up of superficial bladder cancer: how to spare cystoscopies?
    Vera-Donoso CD; Llopis B; Oliver F; Server G; Alonso M; Jimenez-Cruz JF
    Eur Urol; 1990; 17(1):17-9. PubMed ID: 2180718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.
    Beukers W; van der Keur KA; Kandimalla R; Vergouwe Y; Steyerberg EW; Boormans JL; Jensen JB; Lorente JA; Real FX; Segersten U; Orntoft TF; Malats N; Malmström PU; Dyrskjot L; Zwarthoff EC
    J Urol; 2017 Jun; 197(6):1410-1418. PubMed ID: 28049011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.